234 related articles for article (PubMed ID: 10861932)
1. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
Bowen MA; Aruffo AA; Bajorath J
Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues in CD6 which are critical for ligand binding.
Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
[TBL] [Abstract][Full Text] [Related]
3. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Nov; 35(47):14743-8. PubMed ID: 8942635
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the CD6 ligand binding domain.
Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
[TBL] [Abstract][Full Text] [Related]
7. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
8. CD6 recognizes the neural adhesion molecule BEN.
Skonier JE; Bowen MA; Aruffo A; Bajorath J
Protein Sci; 1997 Aug; 6(8):1768-70. PubMed ID: 9260290
[TBL] [Abstract][Full Text] [Related]
9. Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.
Bajorath J; Bowen MA; Aruffo A
Protein Sci; 1995 Aug; 4(8):1644-7. PubMed ID: 8520490
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of CD6 and CD6 ligand in cattle: expression of the CD6 ligand (CD166) in the autonomic nervous system of cattle and the human.
Konno A; Ahn JS; Kitamura H; Hamilton MJ; Gebe JA; Aruffo A; Davis WC
J Leukoc Biol; 2001 Jun; 69(6):944-50. PubMed ID: 11404380
[TBL] [Abstract][Full Text] [Related]
11. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.
Piazza T; Cha E; Bongarzone I; Canevari S; Bolognesi A; Polito L; Bargellesi A; Sassi F; Ferrini S; Fabbi M
J Cell Sci; 2005 Apr; 118(Pt 7):1515-25. PubMed ID: 15769845
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily.
Hohenester E; Sasaki T; Timpl R
Nat Struct Biol; 1999 Mar; 6(3):228-32. PubMed ID: 10074941
[TBL] [Abstract][Full Text] [Related]
13. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
14. CD6-ligand interactions: a paradigm for SRCR domain function?
Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
16. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
17. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
[TBL] [Abstract][Full Text] [Related]
18. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the expression of a second CD6 ligand by synovial fibroblasts.
Joo YS; Singer NG; Endres JL; Sarkar S; Kinne RW; Marks RM; Fox DA
Arthritis Rheum; 2000 Feb; 43(2):329-35. PubMed ID: 10693872
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the tyrosine phosphorylation and calcium fluxing of human CD6 isoforms with different cytoplasmatic domains.
Kobarg J; Whitney GS; Palmer D; Aruffo A; Bowen MA
Eur J Immunol; 1997 Nov; 27(11):2971-80. PubMed ID: 9394826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
